| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and the Cancer Research Institute, University of California, School of Medicine, San Francisco, California
The Gardner 6C3HED lymphosarcoma, Leukemia L-1210, and Leukemia L-1210/aza in ascites form were inhibited in in vivo experiments by a highly purified preparation of glutaminase-asparaginase from a pseudomonad. The glutamine content of tumors was measured by an enzymatic micromethod. The results showed that glutaminase-treated tumors were depleted of free glutamine. The glutamine-synthetase activity in tissues of normal mice has been compared with that of tumor cells. Tumor tissues showed lower activity of this enzyme than did normal tissues. Glycine-14C and adenine-14C incorporation studies in vivo indicated the impairment of both the de novo and the reutilization pathways of purine synthesis. Combination therapy with azaserine-enzyme and 8-azaguanine-enzyme produced an augmentation of tumor inhibition.
1 Aided by research grants from the National Cancer Institute (CA-02915, CA-03175) and the Cancer Research Funds of the University of California.
2 Prepared from a thesis submitted in partial satisfaction for the Ph.D. degree by F. A. El-Asmar to the Graduate Division (San Francisco) of the University of California, January, 1965.
Received 4/ 6/65.
Revised 7/16/65.
This article has been cited by other articles:
![]() |
E. M. Hersh L-Glutaminase: Suppression of Lymphocyte Blastogenic Responses in vitro Science, May 14, 1971; 172(3984): 736 - 738. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |